Literature DB >> 2208062

On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma.

J Limon1, K Mrózek, S Heim, P Elfving, B Nedoszytko, M Babińska, N Mandahl, R Lundgren, F Mitelman.   

Abstract

Cytogenetic analysis of 30 renal cell carcinomas showed 3p aberrations in nine tumors, trisomy 7 in 17 tumors, and clonal loss of one sex chromosome in 14 tumors. The 3p aberrations and trisomy 7 were present in the same clone in two tumors and in separate clones in three tumors. Loss of one sex chromosome was present together with 3p aberrations in the same clone in one tumor and occurred in seemingly unrelated clones in two tumors. It occurred as the sole change in five tumors. Clones with trisomy 7 as the only change were present in six tumors. Trisomy 7 and loss of one sex chromosome were present in separate clones in four tumors and in the same clone in one tumor. Because +7 and -X/-Y were thus rarely present together with clonal structural abnormalities, in particular 3p changes, our findings make it highly unlikely that loss of one sex chromosome or trisomy 7 represents a primary change in renal cell carcinoma. We instead suggest that there is a tendency for normal kidney cells to lose an X or a Y chromosome and also to gain an extra copy of chromosome 7. This tendency is retained by renal carcinoma cells; therefore, trisomy 7 and sex chromosome loss should not be viewed as tumor-specific abnormalities in this context. Whether these simple numerical aberrations reflect in vivo mosaicism or are acquired in vitro remains unresolved.

Entities:  

Mesh:

Year:  1990        PMID: 2208062     DOI: 10.1016/0165-4608(90)90150-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue.

Authors:  R Casalone; P Granata Casalone; E Minelli; P Portentoso; R Righi; E Meroni; A Giudici; D Donati; C Riva; S Salvatore
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

Review 2.  Cytogenetics of cranial base tumors.

Authors:  S M Gollin; I P Janecka
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.